Source comparison
CJC-1295 No DAC Injection Sites: Comparison Table
Before selecting an injection site, researchers must weigh accessibility, fat depth consistency, and ease of rotation across multi-week protocols. The table below compares the three primary subcutaneous zones used for CJC-1295 no DAC administration. Abdomen (2
This comparison does not assign a generated winner or score.
- Before selecting an injection site, researchers must weigh accessibility, fat depth consistency, and ease of rotation across multi-week protocols. The table below compares the three primary subcutaneous zones used for CJC-1295 no DAC administration.
- Abdomen (2–3 inches lateral to navel)
- 15–25mm
- Excellent. Direct visual access and easy reach
- 4–6 discrete sites per side (8–12 total)
- Baseline standard. Consistent across most body types
- Most versatile site for daily protocols; abundant rotation options prevent tissue damage
- Anterior/Lateral Thigh (mid-thigh region)
- 12–22mm
- Excellent. Accessible seated with direct sight line
- 4 discrete sites per leg (8 total)
- Comparable to abdomen; slightly slower in sedentary individuals
- Ideal secondary site; combine with abdomen for 16+ total rotation zones
- Posterior Upper Arm (triceps area)
- 8–18mm (highly variable by body composition)
- Poor for solo injection. Requires assistance or mirror
- 2 sites per arm (4 total)
- Comparable when fat depth is sufficient; risk of IM injection in leaner individuals
- Use only when other sites need rest; not suitable as primary site for lean researchers